Semaglutide Semaglutide (1 mg) ZPHC

Buy Semaglutide (1 mg) ZPHC in Ukraine Semaglutide is an analogue of glucagon-like peptide 1 (GLP-1), 94% identical in sequence to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor. Semaglutide lowers blood glucose levels in a glucose-dependent manner by stimulating insulin secretion and reducing glucagon secretion when blood glucose levels are high. The mechanism for lowering blood glucose levels also involves a slight delay in the process of gastric emptying. During hypoglycemia, semaglutide reduces insulin secretion and does not interfere with glucagon secretion. Semaglutide reduces body weight and body fat mass through a general decrease in appetite. Buy Semaglutide 1 mg Online – Indications • Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus • To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease Semaglutide 1 mg Dosage The starting dose of Semaglutide is 0.25 mg semaglutide once weekly. After 4 weeks, the dose should be increased to 0.5 mg once a week. After at least 4 weeks of 0.5 mg once weekly, the dose may be increased to 1 mg once weekly to further improve glycemic control. Weekly doses exceeding 1 mg are not recommended. Semaglutide is prescribed once a week at any time of the day, with or without food. Semaglutide is injected subcutaneously into the abdomen, thigh, or upper arm. The injection site can be changed without adjusting the dose. Semaglutide should not be administered intravenously or intramuscularly. If necessary, the day of weekly dosing can be changed if the interval between two doses is at least 3 days (>72 hours). After choosing a new day of administration, you should continue taking the drug once a week. Precautions Diabetic ketoacidosis: Semaglutide should not be used in type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Pancreatitis: If pancreatitis is suspected, semaglutide should be discontinued immediately, and if pancreatitis is confirmed, do not restart. Diabetic retinopathy: Patients with diabetic retinopathy should be monitored. Use during pregnancy and lactation Semaglutide should not be used during pregnancy. If the patient wishes to become pregnant, semaglutide should be discontinued at least 2 months before the planned pregnancy. Since a risk to a breastfed baby cannot be excluded, semaglutide should not be used during breastfeeding. Interaction with other drugs Semaglutide slows down the process of gastric emptying and may affect the rate of absorption of concomitantly taken oral drugs. Semaglutide should be used with caution in patients taking oral medications that require rapid gastrointestinal absorption. Overdose In clinical studies, cases of overdose of up to 4 mg at a time and up to 4 mg per week have been reported. The most commonly reported adverse reaction was nausea. There is no specific antidote for semaglutide overdose. In case of overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms. Storage Store at temperatures between 2 C and 8 C (in the refrigerator). Do not freeze. Keep out of the reach of children. You can buy Semaglutide 1 mg online in Ukraine, Kyiv and other cities with cash on delivery. ECA fat burners, clenbuterol, T3, Semaglutide Semaglutide (1 mg) ZPHC